Taking a value-oriented, strategy-driven approach, it outlines the strategic layout for the early R&D of drugs. Taking basic research, regulatory science, clinical research, development strategy, and industrial transformation as the sources of innovation strategies, DIA China Drug Discovery Innovation (DDI) examines the difficulties, pain points, and blocking points faced by source innovation in China; expands the international vision with height and depth; and explores a path with breadth, dimensions, and temperature for for the early R&D of innovative drugs.